Urothelial Cancer
Brightline-2: A Phase IIa/IIb, open-label, single-arm, multi-centre trial of BI 907828 for treatment of patients with locally advanced/ metastatic, MDM2 amplified, TP53 wild-type biliary tract adenocarcinoma, pancreatic ductal adenocarcinoma, or other selected solid tumours. (1403-0011)
- Details
ClinicalTrials.gov ID:
NCT05512377
Diagnosis Type:
NA
USOR Number:
- Address
8820 Huron St
Thornton, CO 80260
P: (303) 386-7622